- Home
- LGVN vs NOM Comparison
LGVN vs NOM Comparison
Compare LGVN & NOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- NOM
- Stock Information
- Founded
- LGVN 2014
- NOM 1993
- Country
- LGVN United States
- NOM United States
- Employees
- LGVN N/A
- NOM N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- NOM Investment Managers
- Sector
- LGVN Health Care
- NOM Finance
- Exchange
- LGVN Nasdaq
- NOM Nasdaq
- Market Cap
- LGVN 23.4M
- NOM 25.0M
- IPO Year
- LGVN 2021
- NOM N/A
- Fundamental
- Price
- LGVN $1.23
- NOM $10.78
- Analyst Decision
- LGVN Strong Buy
- NOM
- Analyst Count
- LGVN 3
- NOM 0
- Target Price
- LGVN $8.67
- NOM N/A
- AVG Volume (30 Days)
- LGVN 132.9K
- NOM 6.9K
- Earning Date
- LGVN 05-08-2025
- NOM 01-01-0001
- Dividend Yield
- LGVN N/A
- NOM 3.39%
- EPS Growth
- LGVN N/A
- NOM N/A
- EPS
- LGVN N/A
- NOM N/A
- Revenue
- LGVN $2,225,000.00
- NOM N/A
- Revenue This Year
- LGVN N/A
- NOM N/A
- Revenue Next Year
- LGVN $24.82
- NOM N/A
- P/E Ratio
- LGVN N/A
- NOM N/A
- Revenue Growth
- LGVN 127.50
- NOM N/A
- 52 Week Low
- LGVN $0.77
- NOM $8.52
- 52 Week High
- LGVN $6.40
- NOM $10.48
- Technical
- Relative Strength Index (RSI)
- LGVN 39.93
- NOM 56.60
- Support Level
- LGVN $1.25
- NOM $10.40
- Resistance Level
- LGVN $1.37
- NOM $10.89
- Average True Range (ATR)
- LGVN 0.09
- NOM 0.13
- MACD
- LGVN -0.01
- NOM -0.01
- Stochastic Oscillator
- LGVN 30.00
- NOM 80.00
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About NOM Nuveen Missouri Quality Municipal Income Fund
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in United States. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Missouri state income taxes; its secondary investment objective is the enhancement of portfolio value. The fund invests in municipal securities as well as floating rate securities as well as derivatives such as futures, options and swap contracts to the necessary extent. Nuveen Fund Advisors, LLC acts as an investment adviser of the company.